BioLife Solutions (BLFS) Presents At Cowen and Comapny 40th Annual Health Care Conference - Slideshow

Company Overview - BioLife Solutions aims to be a leading supplier of bioproduction tools for cell and gene therapy in the regenerative medicine industry[5] - The company has a portfolio of products designed to improve the quality and de-risk cell and gene therapy manufacturing and delivery[7] - BioLife Solutions' products are used in nearly 400 customer applications[9] - The company is executing an M&A strategy to scale faster and solve more customer problems[11] Market and Products - The cell and gene therapy market is growing rapidly, rewarding innovators who can de-risk manufacturing, storage, and delivery[16] - BioLife Solutions offers biopreservation media, automated thawing products, cloud-connected shipping containers, and high-capacity storage freezers[14] - The company's biopreservation media, CryoStor and HypoThermosol, have demonstrated efficacy in over 425 articles, abstracts, and posters[30] - In 2019, SAVSU Technologies shipped 1,500 shipments using its cloud-connected shippers[56] Financial Performance - From January to September 2019, BioLife Solutions' revenue was $19 million, a 33% increase compared to $14.3 million in the same period of 2018[64] - The adjusted gross margin for January to September 2019 was 71%, a 200 bps increase from 69% in the same period of 2018[64] - Adjusted EBITDA for January to September 2019 was $4.3 million, a 7% increase compared to $4 million in the same period of 2018[64]